These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29462984)

  • 1. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
    Kleppe R; Jonassen I; Døskeland SO; Selheim F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.
    Degjoni A; Campolo F; Stefanini L; Venneri MA
    J Thromb Haemost; 2022 Nov; 20(11):2465-2474. PubMed ID: 35950928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
    Wilson LS; Guo M; Umana MB; Maurice DH
    Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.
    Dickinson NT; Jang EK; Haslam RJ
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):371-7. PubMed ID: 9163326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
    Wilson LS; Elbatarny HS; Crawley SW; Bennett BM; Maurice DH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13650-5. PubMed ID: 18757735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
    Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
    Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel roles of cAMP/cGMP-dependent signaling in platelets.
    Smolenski A
    J Thromb Haemost; 2012 Feb; 10(2):167-76. PubMed ID: 22136590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
    Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
    Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation.
    Wangorsch G; Butt E; Mark R; Hubertus K; Geiger J; Dandekar T; Dittrich M
    BMC Syst Biol; 2011 Oct; 5():178. PubMed ID: 22034949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
    Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
    Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
    Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
    Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds.
    Margarucci L; Roest M; Preisinger C; Bleijerveld OB; van Holten TC; Heck AJ; Scholten A
    Mol Biosyst; 2011 Jul; 7(7):2311-9. PubMed ID: 21597619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5.
    Jäger R; Schwede F; Genieser HG; Koesling D; Russwurm M
    Br J Pharmacol; 2010 Dec; 161(7):1645-60. PubMed ID: 20698857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.